Creative Realities (CREX) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
3 Dec, 2025Executive summary
Annual meeting scheduled for December 29, 2025, to vote on key proposals including director elections, auditor ratification, executive compensation, Series A Preferred Stock conversion, and potential adjournment if needed.
Shareholders of record as of November 26, 2025, are eligible to vote; both Common Stock and Series A Preferred Stock holders participate, subject to certain limitations.
Proxy materials and the 2024 Annual Report are available online; voting can be done by mail, phone, or internet.
Voting matters and shareholder proposals
Six directors are up for election to serve until the next annual meeting.
Ratification of Grant Thornton LLP as independent auditor for fiscal 2025 is proposed.
Advisory vote on executive compensation (say-on-pay) is included.
Approval sought for issuance of Common Stock upon conversion of Series A Preferred Stock, exceeding current ownership and exchange caps, and related change of control under Nasdaq rules.
Adjournment proposal allows the meeting to be postponed to solicit additional proxies if necessary.
Shareholder proposals for the 2026 meeting are due by August 5, 2026, with specific requirements for director nominations and universal proxy rules.
Board of directors and corporate governance
Board consists of six members, four of whom are independent under Nasdaq rules.
Chairman and CEO roles are combined; majority of the board is independent to provide oversight.
Board committees include Audit and Compensation; no separate nominating committee, with independent directors handling nominations.
Audit Committee met four times in 2024; Compensation Committee did not meet in 2024.
Lead Investor (North Run) has director designation rights based on ownership, with changes to board size and composition contingent on shareholder approval of the Series A Conversion Proposal.
Latest events from Creative Realities
- Record Q2 revenue and margin gains, but 2025 contingent liability creates liquidity risk.CREX
Q2 20241 Feb 2026 - Record SaaS growth, major client wins, and global expansion drive ambitious $150M revenue target.CREX
17th Annual LD Micro Main Event Conference18 Jan 2026 - Record Q3 revenue and profitability, but liquidity risks persist from contingent liabilities.CREX
Q3 202414 Jan 2026 - Record year with Q4 dip, but ARR and new platform set up strong 2025 growth.CREX
Q4 202426 Dec 2025 - Large secondary offering enables major shareholders to resell over half of outstanding shares.CREX
Registration Filing19 Dec 2025 - Resale registration for 3.16M shares, including 1.73M warrant shares, with no new capital raised.CREX
Registration Filing16 Dec 2025 - Annual meeting to elect directors, approve equity plan, and ratify new auditor, with focus on governance.CREX
Proxy Filing1 Dec 2025 - Proxy statement supplement details proxy solicitor engagement, no agenda changes for annual meeting.CREX
Proxy Filing1 Dec 2025 - Net income surged on a one-time gain, but liquidity and growth risks remain.CREX
Q1 202526 Nov 2025